| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.07 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.015 | 0.7 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.067 | 0.05 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.06 | 0.09 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.049 | 0.3 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |